Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
4.000
+0.030 (0.76%)
Sep 24, 2026, 9:43 AM EDT - Market open
Edesa Biotech Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 10.33 | 10.79 | 1.04 | 5.36 | 7.09 | 7.84 |
Cash & Short-Term Investments | 10.33 | 10.79 | 1.04 | 5.36 | 7.09 | 7.84 |
Cash Growth | -16.41% | 940.39% | -80.65% | -24.39% | -9.55% | 8.67% |
Other Receivables | 0.23 | 0.64 | 0.27 | 0.63 | 1.26 | 3.3 |
Receivables | 0.23 | 0.64 | 0.27 | 0.63 | 1.26 | 3.3 |
Prepaid Expenses | 0.22 | 0.08 | 0.37 | 0.45 | 0.75 | 0.95 |
Total Current Assets | 10.78 | 11.51 | 1.68 | 6.44 | 9.09 | 12.09 |
Property, Plant & Equipment | - | - | 0.02 | 0.1 | 0.03 | 0.11 |
Other Intangible Assets | 1.9 | 1.98 | 2.08 | 2.18 | 2.28 | 2.38 |
Other Long-Term Assets | 0.04 | 0.04 | 0.04 | 0.17 | 0.17 | - |
Total Assets | 12.72 | 13.53 | 3.81 | 8.89 | 11.58 | 14.58 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Accounts Payable | 3.91 | 1.08 | 1.81 | 1.75 | 2.12 | 1.38 |
Current Portion of Leases | - | - | 0.02 | 0.07 | 0.02 | 0.08 |
Total Current Liabilities | 3.91 | 1.08 | 1.83 | 1.82 | 2.14 | 1.46 |
Long-Term Leases | - | - | - | 0.02 | - | 0.02 |
Other Long-Term Liabilities | - | - | - | - | 0.04 | 0.05 |
Total Liabilities | 3.91 | 1.08 | 1.83 | 1.84 | 2.18 | 1.53 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Common Stock | 62.42 | 54.52 | 47.24 | 46.64 | 42.47 | 34.89 |
Additional Paid-In Capital | 16.04 | 14.75 | 13.58 | 13.04 | 11.18 | 4.87 |
Retained Earnings | -77.9 | -65.91 | -58.59 | -52.42 | -44.04 | -26.5 |
Comprehensive Income & Other | -0.16 | -0.17 | -0.24 | -0.21 | -0.21 | -0.21 |
Total Common Equity | 0.4 | 3.19 | 1.98 | 7.05 | 9.39 | 13.06 |
Shareholders' Equity | 8.81 | 12.45 | 1.98 | 7.05 | 9.39 | 13.06 |
Total Liabilities & Equity | 12.72 | 13.53 | 3.81 | 8.89 | 11.58 | 14.58 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Total Debt | - | - | 0.02 | 0.09 | 0.02 | 0.1 |
Net Cash (Debt) | 10.33 | 10.79 | 1.02 | 5.27 | 7.07 | 7.74 |
Net Cash Growth | -16.41% | 960.70% | -80.68% | -25.52% | -8.63% | 9.79% |
Net Cash Per Share | 1.27 | 1.90 | 0.32 | 1.84 | 3.37 | 4.49 |
Filing Date Shares Outstanding | 9.64 | 8.33 | 3.47 | 3.16 | 2.76 | 1.93 |
Total Common Shares Outstanding | 9.63 | 7.14 | 3.25 | 3.08 | 2.38 | 1.9 |
Working Capital | 6.87 | 10.43 | -0.16 | 4.61 | 6.95 | 10.63 |
Book Value Per Share | 0.04 | 0.45 | 0.61 | 2.29 | 3.95 | 6.88 |
Tangible Book Value | -1.5 | 1.21 | -0.1 | 4.87 | 7.11 | 10.68 |
Tangible Book Value Per Share | -0.16 | 0.17 | -0.03 | 1.58 | 2.99 | 5.62 |
Machinery | - | - | - | 0.05 | 0.05 | 0.05 |